255 Chronic Hepatitis B Genotype B or C E Antigen Positive Patients: Viral Suppression, HBeAg Loss and Seroconversion Rates Are Improved with Telbivudine Compared with Lamivudine - Results from a Pooled Analysis

Journal article

Peer reviewed

Christopher B O'Brien, Jidong Jia and Gillian Zeldin

Gastroenterology (New York, N.Y. 1943), Vol.134(4), pp.A-760-A-760

2008-04

Metrics

11 Record Views

Title: 255 Chronic Hepatitis B Genotype B or C E Antigen Positive Patients: Viral Suppression, HBeAg Loss and Seroconversion Rates Are Improved with Telbivudine Compared with Lamivudine - Results from a Pooled Analysis
Creators: Christopher B O'Brien
Jidong Jia
Gillian Zeldin
Publication Details: Gastroenterology (New York, N.Y. 1943), Vol.134(4), pp.A-760-A-760
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hepatology
Language: English
Resource Type: Journal article
Record Identifier: 991031598802702976